Literature DB >> 2079995

Effect of corticosteroids on some hemostatic parameters in children with minimal change nephrotic syndrome.

N Ueda1.   

Abstract

Effect of corticosteroids (steroids) on some hemostatic parameters was serially studied in 23 children with minimal change nephrotic syndrome (MCNS). Increased platelet count, erythrocyte sedimentation rate (ESR), cholesterol, fibrinogen, fibrin(ogen) degradation products (FDP), alpha 2-macroglobulin (alpha 2M), alpha 2-antiplasmin (alpha 2AP) and protein C, and reduced antithrombin III (ATIII) and plasminogen (Plg) were noted in relapse before steroid therapy began. With institution of oral prednisolone, FDP started to fall, and platelet count, cholesterol, alpha 2M, ATIII, Plg, alpha 2AP and protein C started to increase despite unchanged nephrotic state from that before the therapy. In remission induced by prednisolone, platelet count, cholesterol, alpha 2M, ATIII, Plg, alpha 2AP and protein C were still increased, but normalized off therapy. ESR, fibrinogen, FDP, alpha 2M and protein C correlated inversely with serum albumin and directly with cholesterol and urine protein excretion. In contrast, ATIII and Plg correlated directly with serum albumin and inversely with cholesterol and urine protein excretion. A direct correlation was only noted between alpha 2AP and the dose of prednisolone. The data indicate that steroids appear to be a thrombogenic factor by accerelating thrombocytosis and hyperlipidemia, and by reducing plasma fibrinolysis in children with MCNS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2079995     DOI: 10.1159/000186178

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  9 in total

1.  Haemostatic parameters in childhood nephrotic syndrome. (Is there any difference in protein C levels between steroid sensitive and resistant groups?)

Authors:  F Yalçinkaya; N Tümer; A N Gorgani; M Ekim; N Cakar
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

Review 2.  Treatment of idiopathic membranous nephropathy.

Authors:  Julia M Hofstra; Fernando C Fervenza; Jack F M Wetzels
Journal:  Nat Rev Nephrol       Date:  2013-07-02       Impact factor: 28.314

Review 3.  Cerebral sinovenous thrombosis and idiopathic nephrotic syndrome in childhood: report of four new cases and review of the literature.

Authors:  Joel Fluss; Denis Geary; Gabrielle deVeber
Journal:  Eur J Pediatr       Date:  2006-05-12       Impact factor: 3.183

Review 4.  Platelet abnormalities in nephrotic syndrome.

Authors:  Benedicte Eneman; Elena Levtchenko; Bert van den Heuvel; Chris Van Geet; Kathleen Freson
Journal:  Pediatr Nephrol       Date:  2015-08-13       Impact factor: 3.714

5.  Bilateral iliac and popliteal arterial thrombosis in a child with focal segmental glomerulosclerosis.

Authors:  Kyoung Hee Han; Ji Youn Park; Seung-Kee Min; Il-Soo Ha; Hae Il Cheong; Hee Gyung Kang
Journal:  Korean J Pediatr       Date:  2016-05-31

Review 6.  Thrombosis Complications in Pediatric Acute Lymphoblastic Leukemia: Risk Factors, Management, and Prevention: Is There Any Role for Pharmacologic Prophylaxis?

Authors:  Vilmarie Rodriguez
Journal:  Front Pediatr       Date:  2022-03-10       Impact factor: 3.418

7.  Urinary exosomes reveal protein signatures in hypertensive patients with albuminuria.

Authors:  Laura Gonzalez-Calero; Paula J Martínez; Marta Martin-Lorenzo; Montserrat Baldan-Martin; Gema Ruiz-Hurtado; Fernando de la Cuesta; Eva Calvo; Julian Segura; Juan Antonio Lopez; Jesús Vázquez; Maria G Barderas; Luis M Ruilope; Fernando Vivanco; Gloria Alvarez-Llamas
Journal:  Oncotarget       Date:  2017-07-04

8.  Nephrotic syndrome-associated hypercoagulopathy is alleviated by both pioglitazone and glucocorticoid which target two different nuclear receptors.

Authors:  Amanda P Waller; Shipra Agrawal; Katelyn J Wolfgang; Jiro Kino; Melinda A Chanley; William E Smoyer; Bryce A Kerlin
Journal:  Physiol Rep       Date:  2020-08

9.  Risk factors for thrombotic events in Korean patients with systemic lupus erythematosus.

Authors:  Dong-Jin Park; Chang-Seok Yoon; Sung-Eun Choi; Haimuzi Xu; Ji-Hyoun Kang; Shin-Seok Lee
Journal:  Sci Rep       Date:  2021-12-07       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.